Boston Scientific Corporation is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
Boston Scientific Corporation is an American manufacturer of minimally invasive interventional medical devices. Among its areas of expertise are endoscopy, interventional cardiology, neuromodulation, and peripheral interventions for arterial diseases, venous disease, and cancer.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Medical device research and development is responsible for substantive gains in length and quality of life, perhaps most profoundly in fighting cardiovascular disease. Boston Scientific Corp. generates positive Humankind Value on balance. The greatest contributors to this positive outcome are Medical Devices ($58.0 B), Medical Services ($3.9 B), and Economic Value ($2.8 B). Positive value from Medical Devices and Medical Services contains our estimation of 1,285,690.8 additional years lived by people worldwide. It creates economic value by offering to consumers goods and services that they value, paying employees for their labor in producing these goods and services, and providing value for shareholders. This firm can increase its Humankind Value by addressing Greenhouse Gases (-$387.3 M) and Opioid Abuse (-$348.9 M). Medical Devices and Economic Value are attached to this company as a result of its direct business activities. Medical Services, Greenhouse Gases, and Opioid Abuse are mostly or entirely a result of supply-chain relationships.